Skip to main content
Top
Published in: Journal of Neurology 5/2013

01-05-2013 | Original Communication

Time trends in incidence of Parkinson’s disease diagnosis in UK primary care

Authors: Laura Horsfall, Irene Petersen, Kate Walters, Anette Schrag

Published in: Journal of Neurology | Issue 5/2013

Login to get access

Abstract

To examine time trends and the influence of socio-demographic and geographic factors on incidence of Parkinson’s disease (PD) diagnosis in a large UK population-based cohort from The Health Improvement Network (THIN), a UK primary care database. All patients aged over 50 years and contributing data to THIN between January 1999 and December 2009 were extracted and the incidence rates of PD diagnoses were determined by age, gender, time period, social deprivation score and urban/rural status. The overall incidence of PD diagnosis for people over 50 years was 84 per 100,000 person years (95 % CI 82–85). After accounting for socio-demographic factors, the adjusted incidence rates in men were 46 % higher (95 % CI 43–48 %) than in women. Adjusted incidence rates were also 12 % higher in urban than rural areas (95 % CI 4–20 %) and slightly lower in less socially deprived areas. Over time there was a downward trend in PD diagnosis with the adjusted incidence rates declining by around 6 % every calendar year (95 % CI 5–6 %) between 1999 and 2009. Broadening the definition of PD from diagnostic codes to include symptoms and antiparkinsonian drug prescriptions increased the overall incidence to 118 per 100,000 person years (95 % CI 116–120) and showed a much weaker downward trend over time of around 1 % per calendar year (95 % CI 1–2 %). With the broader definition, the adjusted incidence rates remained significantly higher in men compared to women and in urban areas compared with rural areas but not in socially deprived areas. The PD diagnosis rates in the primary care setting were, as expected, higher in men, and slightly higher in urban areas, but not different between socio-economic groups. There was a decline in PD diagnosis in the primary care setting, which may largely represent changes in diagnosis and/or coding rather than a true decline in incidence.
Literature
1.
go back to reference de Rijk MC, Tzourio C, Breteler MM, Dartigues JF, Amaducci L, Lopez-Pousa S et al (1997) Prevalence of parkinsonism and Parkinson’s disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson’s disease. J Neurol Neurosurg Psychiatry 62(1):10–15PubMedCrossRef de Rijk MC, Tzourio C, Breteler MM, Dartigues JF, Amaducci L, Lopez-Pousa S et al (1997) Prevalence of parkinsonism and Parkinson’s disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson’s disease. J Neurol Neurosurg Psychiatry 62(1):10–15PubMedCrossRef
2.
go back to reference Wickremaratchi MM, Perera D, O’Loghlen C, Sastry D, Morgan E, Jones A et al (2009) Prevalence and age of onset of Parkinson’s disease in Cardiff: a community based cross sectional study and meta-analysis. J Neurol Neurosurg Psychiatry 80(7):805–807PubMedCrossRef Wickremaratchi MM, Perera D, O’Loghlen C, Sastry D, Morgan E, Jones A et al (2009) Prevalence and age of onset of Parkinson’s disease in Cardiff: a community based cross sectional study and meta-analysis. J Neurol Neurosurg Psychiatry 80(7):805–807PubMedCrossRef
4.
go back to reference Dick FD, De Palma G, Ahmadi A, Scott NW, Prescott GJ, Bennett J et al (2007) Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study. Occup Environ Med 64(10):666–672PubMedCrossRef Dick FD, De Palma G, Ahmadi A, Scott NW, Prescott GJ, Bennett J et al (2007) Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study. Occup Environ Med 64(10):666–672PubMedCrossRef
5.
go back to reference Dick FD, De Palma G, Ahmadi A, Osborne A, Scott NW, Prescott GJ et al (2007) Gene-environment interactions in parkinsonism and Parkinson’s disease: the Geoparkinson study. Occup Environ Med 64(10):673–680PubMedCrossRef Dick FD, De Palma G, Ahmadi A, Osborne A, Scott NW, Prescott GJ et al (2007) Gene-environment interactions in parkinsonism and Parkinson’s disease: the Geoparkinson study. Occup Environ Med 64(10):673–680PubMedCrossRef
6.
go back to reference Biskup S, Gerlach M, Kupsch A, Reichmann H, Riederer P, Vieregge P et al (2008) Genes associated with Parkinson syndrome. J Neurol 255(Suppl 5):8–17PubMedCrossRef Biskup S, Gerlach M, Kupsch A, Reichmann H, Riederer P, Vieregge P et al (2008) Genes associated with Parkinson syndrome. J Neurol 255(Suppl 5):8–17PubMedCrossRef
7.
go back to reference Hancock DB, Martin ER, Stajich JM, Jewett R, Stacy MA, Scott BL et al (2007) Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease. Arch Neurol 64(4):576–580PubMedCrossRef Hancock DB, Martin ER, Stajich JM, Jewett R, Stacy MA, Scott BL et al (2007) Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease. Arch Neurol 64(4):576–580PubMedCrossRef
8.
go back to reference Kuopio AM, Marttila RJ, Helenius H, Rinne UK (1999) Changing epidemiology of Parkinson’s disease in southwestern Finland. Neurology 52(2):302–308PubMedCrossRef Kuopio AM, Marttila RJ, Helenius H, Rinne UK (1999) Changing epidemiology of Parkinson’s disease in southwestern Finland. Neurology 52(2):302–308PubMedCrossRef
9.
go back to reference Tandberg E, Larsen JP, Nessler EG, Riise T, Aarli JA (1995) The epidemiology of Parkinson’s disease in the county of Rogaland, Norway. Mov Disord 10(5):541–549PubMedCrossRef Tandberg E, Larsen JP, Nessler EG, Riise T, Aarli JA (1995) The epidemiology of Parkinson’s disease in the county of Rogaland, Norway. Mov Disord 10(5):541–549PubMedCrossRef
10.
go back to reference Peters CM, Gartner CE, Silburn PA, Mellick GD (2006) Prevalence of Parkinson’s disease in metropolitan and rural Queensland: a general practice survey. J Clin Neurosci 13(3):343–348PubMedCrossRef Peters CM, Gartner CE, Silburn PA, Mellick GD (2006) Prevalence of Parkinson’s disease in metropolitan and rural Queensland: a general practice survey. J Clin Neurosci 13(3):343–348PubMedCrossRef
11.
go back to reference Chen CC, Chen TF, Hwang YC, Wen YR, Chiu YH, Wu CY et al (2009) Different prevalence rates of Parkinson’s disease in urban and rural areas: a population-based study in Taiwan. Neuroepidemiology 33(4):350–357PubMedCrossRef Chen CC, Chen TF, Hwang YC, Wen YR, Chiu YH, Wu CY et al (2009) Different prevalence rates of Parkinson’s disease in urban and rural areas: a population-based study in Taiwan. Neuroepidemiology 33(4):350–357PubMedCrossRef
13.
go back to reference Townsend P (1986) Inequalities in health in the northern region : an interim report. University of Bristol, Bristol Townsend P (1986) Inequalities in health in the northern region : an interim report. University of Bristol, Bristol
14.
go back to reference Bourke A, Dattani H, Robinson M (2004) Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care 12(3):171–177PubMed Bourke A, Dattani H, Robinson M (2004) Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care 12(3):171–177PubMed
15.
go back to reference Maguire A, Blak BT, Thompson M (2009) The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf 18(1):76–83PubMedCrossRef Maguire A, Blak BT, Thompson M (2009) The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf 18(1):76–83PubMedCrossRef
16.
go back to reference Horsfall L, Walter K (2012) Petersen I. Identifying periods of acceptable computer usage in primary care research databases, Pharmacoepidemiol Drug Saf Horsfall L, Walter K (2012) Petersen I. Identifying periods of acceptable computer usage in primary care research databases, Pharmacoepidemiol Drug Saf
17.
go back to reference Lewis JD, Bilker WB, Weinstein RB, Strom BL (2005) The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf 14(7):443–451PubMedCrossRef Lewis JD, Bilker WB, Weinstein RB, Strom BL (2005) The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf 14(7):443–451PubMedCrossRef
18.
go back to reference Dave S, Petersen I (2009) Creating medical and drug code lists to identify cases in primary care databases. Pharmacoepidemiol Drug Saf 18(8):704–707PubMedCrossRef Dave S, Petersen I (2009) Creating medical and drug code lists to identify cases in primary care databases. Pharmacoepidemiol Drug Saf 18(8):704–707PubMedCrossRef
19.
go back to reference Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS (2001) Environmental risk factors and Parkinson’s disease: a metaanalysis. Environ Res 86(2):122–127PubMedCrossRef Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS (2001) Environmental risk factors and Parkinson’s disease: a metaanalysis. Environ Res 86(2):122–127PubMedCrossRef
20.
go back to reference Lix LM, Hobson DE, Azimaee M, Leslie WD, Burchill C, Hobson S (2010) Socioeconomic variations in the prevalence and incidence of Parkinson’s disease: a population-based analysis. J Epidemiol Community Health 64(4):335–340PubMedCrossRef Lix LM, Hobson DE, Azimaee M, Leslie WD, Burchill C, Hobson S (2010) Socioeconomic variations in the prevalence and incidence of Parkinson’s disease: a population-based analysis. J Epidemiol Community Health 64(4):335–340PubMedCrossRef
21.
go back to reference MacDonald BK, Cockerell OC, Sander JW, Shorvon SD (2000) The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 123(Pt 4):665–676PubMedCrossRef MacDonald BK, Cockerell OC, Sander JW, Shorvon SD (2000) The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 123(Pt 4):665–676PubMedCrossRef
22.
go back to reference van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A (2001) Estimation of incidence and prevalence of Parkinson’s disease in the elderly using pharmacy records. Pharmacoepidemiol Drug Saf 10(6):549–554PubMedCrossRef van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A (2001) Estimation of incidence and prevalence of Parkinson’s disease in the elderly using pharmacy records. Pharmacoepidemiol Drug Saf 10(6):549–554PubMedCrossRef
23.
go back to reference Rait G, Walters K, Griffin M, Buszewicz M, Petersen I, Nazareth I (2009) Recent trends in the incidence of recorded depression in primary care. Br J Psychiatry 195(6):520–524PubMedCrossRef Rait G, Walters K, Griffin M, Buszewicz M, Petersen I, Nazareth I (2009) Recent trends in the incidence of recorded depression in primary care. Br J Psychiatry 195(6):520–524PubMedCrossRef
24.
go back to reference Rocca WA, Bower JH, McDonnell SK, Peterson BJ, Maraganore DM (2001) Time trends in the incidence of parkinsonism in Olmsted County, Minnesota. Neurology 57(3):462–467PubMedCrossRef Rocca WA, Bower JH, McDonnell SK, Peterson BJ, Maraganore DM (2001) Time trends in the incidence of parkinsonism in Olmsted County, Minnesota. Neurology 57(3):462–467PubMedCrossRef
25.
go back to reference Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA et al (2003) Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157(11):1015–1022CrossRef Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA et al (2003) Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157(11):1015–1022CrossRef
26.
go back to reference Twelves D, Perkins KS, Counsell C (2003) Systematic review of incidence studies of Parkinson’s disease. Mov Disord 18(1):19–31PubMedCrossRef Twelves D, Perkins KS, Counsell C (2003) Systematic review of incidence studies of Parkinson’s disease. Mov Disord 18(1):19–31PubMedCrossRef
27.
go back to reference Adams J, Ryan V, White M (2005) How accurate are Townsend Deprivation Scores as predictors of self-reported health? A comparison with individual level data. J Public Health 27(1):101–106CrossRef Adams J, Ryan V, White M (2005) How accurate are Townsend Deprivation Scores as predictors of self-reported health? A comparison with individual level data. J Public Health 27(1):101–106CrossRef
28.
go back to reference Krieger N, Williams DR, Moss NE (1997) Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Publ Health 18:341–378CrossRef Krieger N, Williams DR, Moss NE (1997) Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Publ Health 18:341–378CrossRef
29.
go back to reference Grundy E, Holt G (2001) The socioeconomic status of older adults: how should we measure it in studies of health inequalities? J Epidemiol Community Health 55(12):895–904PubMedCrossRef Grundy E, Holt G (2001) The socioeconomic status of older adults: how should we measure it in studies of health inequalities? J Epidemiol Community Health 55(12):895–904PubMedCrossRef
Metadata
Title
Time trends in incidence of Parkinson’s disease diagnosis in UK primary care
Authors
Laura Horsfall
Irene Petersen
Kate Walters
Anette Schrag
Publication date
01-05-2013
Publisher
Springer-Verlag
Published in
Journal of Neurology / Issue 5/2013
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-012-6804-z

Other articles of this Issue 5/2013

Journal of Neurology 5/2013 Go to the issue